Physician profile
Billy J Evans
NPI 1114942422
$1,585.73
in general payments reported to CMS, 2019-2025
20 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2021: $112 · 2022: $156 · 2023: $163 · 2024: $515 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $281.74 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $269.85 | 2021-2025 | Ozempic, Rybelsus |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $124.48 | 2019 | |
| Pfizer INC. | $120.68 | 2019 | |
| Corcept Therapeutics | $90.00 | 2025 | Korlym |
| Abbott Laboratories | $87.47 | 2024-2025 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $73.72 | 2024 | Inspire |
| Lilly USA, LLC | $57.24 | 2022-2025 | Kisunla, Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $52.42 | 2023-2025 | Shingrix, Arexvy |
| Shield Therapeutics INC | $45.19 | 2023-2024 | Accrufer |
| Abbvie INC. | $42.39 | 2023-2025 | |
| Eisai INC. | $39.79 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.77 | 2023 | |
| Covidien LP | $30.37 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $29.64 | 2024-2025 | Zoryve |
| Otsuka America Pharmaceutical, INC. | $28.03 | 2024 | Rexulti |
| Exact Sciences Corporation | $23.97 | 2025 | Cologuard Collection Kit |
| Teleflex LLC | $18.78 | 2022 | |
| Amgen INC. | $14.21 | 2024 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.